pargyline has been researched along with Cataract in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Befani, O | 1 |
| Missiroli, F | 1 |
| Mondovi, B | 1 |
| Mueller, FO | 1 |
| Magos, L | 1 |
2 other studies available for pargyline and Cataract
| Article | Year |
|---|---|
Histaminase (diamine oxidase) activity in human cataract.
Topics: Amine Oxidase (Copper-Containing); Amino Acid Oxidoreductases; Cataract; Enzyme Inhibitors; Humans; | 1999 |
Reversible lenticular opacities induced in rats by emotional stress.
Topics: Animals; Cataract; Catecholamines; Epinephrine; Humans; Male; Pargyline; Rats; Stress, Psychological | 1970 |